+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
U.S. Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), Product, Service, Workflow, Therapeutic Area, End Use, and Growth Forecasts, 2025-2033- Product Image
U.S. Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), Product, Service, Workflow, Therapeutic Area, End Use, and Growth Forecasts, 2025-2033- Product Image
New

U.S. Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), Product, Service, Workflow, Therapeutic Area, End Use, and Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2025
  • Region: United States
  • Grand View Research
  • ID: 6176788
REQUEST CUSTOMIZATION
Description Jump to:
The U.S. healthcare contract development and manufacturing organization market size was estimated at USD 70.2 Billion in 2025 and is projected to reach USD 144.2 billion by 2033, growing at a CAGR of 9.41% from 2025 to 2033. The U.S. healthcare CDMO market is expanding rapidly, driven by rising demand for biologics, biosimilars, and advanced therapies, including cell and gene therapies. Besides, pharmaceutical companies are increasingly focused on R&D in oncology, rare diseases, and immunology, creating the need for highly specialized manufacturing expertise.

CDMOs provide critical infrastructure, scalability, and technical capabilities that many firms lack internally. Growth is further reinforced by strong pipeline activity, patent expirations of biologics, and the acceleration of personalized medicine. This has led CDMOs to become essential partners in enabling faster development timelines, cost efficiency, and compliant production of complex therapies. Pharmaceutical and biotech companies are partnering with CDMOs to reduce operational costs and accelerate product development. Besides, among pharmaceutical companies, establishing in-house facilities requires substantial capital investment, workforce training, and regulatory compliance, which may slow innovation, which has further led to the rise of CDMO services.

In addition, CDMOs offer pharmaceutical and medical device companies’ immediate access to advanced technologies, large-scale facilities, and flexible production models. This partnership supports minimizing the financial risks and allows pharma companies to focus on core R&D while leveraging CDMOs for clinical and commercial manufacturing. In a highly competitive market where speed is critical, CDMOs offer an agile and cost-efficient pathway to bring drugs to market faster, ensuring competitive advantage and profitability.

The U.S. healthcare industry operates under stringent FDA and global regulatory frameworks, requiring strict adherence to GMP standards, validation, and documentation. Besides, navigating these compliance requirements can be highly resource-intensive for pharma companies. CDMOs, however, possess deep regulatory expertise, established quality systems, and experience managing global submissions, reducing the risk of delays and non-compliance. Their ability to consistently meet evolving regulatory standards enhances trust and reliability. In addition, CDMOs are investing in digitalization, automation, and data-driven compliance systems to strengthen oversight. This regulatory know-how makes CDMOs indispensable strategic partners, enabling pharma companies to focus on innovation while ensuring product quality and patient safety.

U.S. Healthcare Contract Development And Manufacturing Organization Market Report Segmentation

This report forecasts revenue growth at and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. healthcare contract development and manufacturing organization market report based on type, product, service, workflow, therapeutic area, and end use:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Small Molecule
  • Branded
  • Generic
  • Large Molecule
  • Biologics
  • Biosimilar
  • Medical Device
  • Diagnostics
  • Therapeutics

Product Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical
  • API
  • Drug Product
  • Medical Devices
  • Class I
  • Class II
  • Class III

Service Outlook (Revenue, USD Million, 2021-2033)

  • Contract Development
  • Pre-formulation & Formulation Development Service
  • Process Development & Optimization
  • Analytical Testing & Method Validation
  • Scale-up & Tech Transfer
  • Contract Manufacturing
  • API Manufacturing
  • Finished drug products Manufacturing
  • Medical Devices & Combination Products
  • Packaging and labelling
  • Regulatory Affairs
  • Others

Workflow Outlook (Revenue, USD Million, 2021-2033)

  • Clinical
  • Commercial

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Oncology
  • Infectious Diseases
  • Neurological Disorders
  • Cardiovascular Disease
  • Metabolic Disorders
  • Autoimmune Diseases
  • Respiratory Diseases
  • Ophthalmology
  • Gastrointestinal Disorders
  • Orthopedic Diseases
  • Dental Diseases
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Others

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Product
1.2.3. Service
1.2.4. Workflow
1.2.5. Therapeutic Area
1.2.6. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Healthcare Contract Development and Manufacturing Organization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. U.S. Healthcare Contract Development and Manufacturing Organization Market: Type Estimates & Trend Analysis
4.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Type: Segment Dashboard
4.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Type: Movement Analysis
4.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Type, 2021-2033 (USD Million)
4.4. Small Molecule
4.4.1. Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Branded
4.4.2.1. Branded Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Generic
4.4.3.1. Generic Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Large Molecule
4.5.1. Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Biologics
4.5.2.1. Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Biosimilar
4.5.3.1. Biosimilar Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Medical Device
4.6.1. Medical Device Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.2. Diagnostics
4.6.2.1. Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6.3. Therapeutics
4.6.3.1. Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Healthcare Contract Development and Manufacturing Organization Market: Product Estimates & Trend Analysis
5.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Product: Segment Dashboard
5.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Product: Movement Analysis
5.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Product, 2021-2033 (USD Million)
5.4. Pharmaceutical
5.4.1. Pharmaceutical Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2. API
5.4.2.1. API Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2.2. Traditional API
5.4.2.2.1. Traditional API Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2.3. HP-API
5.4.2.3.1. HP-API Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2.4. Biologics
5.4.2.4.1. Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.2.5. Others
5.4.2.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3. Drug Product
5.4.3.1. Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3.2. Oral Topical Dose
5.4.3.2.1. Oral Topical Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3.3. Semi-Solid Dose
5.4.3.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3.4. Liquid Dose
5.4.3.4.1. Liquid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
5.4.3.5. Others
5.4.3.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Medical Devices
5.5.1. Medical Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.2. Class I
5.5.2.1. Class I Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.3. Class II
5.5.3.1. Class II Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5.4. Class III
5.5.4.1. Class III Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Healthcare Contract Development and Manufacturing Organization Market: Service Estimates & Trend Analysis
6.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Service: Segment Dashboard
6.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Service: Movement Analysis
6.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Service, 2021-2033 (USD Million)
6.4. Contract Development
6.4.1. Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. Preformulation & Formulation Development Service
6.4.2.1. Preformulation & Formulation Development Services Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Process Development & Optimization
6.4.3.1. Process Development & Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Analytical Testing & Method Validation
6.4.4.1. Analytical Testing & Method Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Scale-up & Tech Transfer
6.4.5.1. Scale-up & Tech Transfer Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Contract Manufacturing
6.5.1. Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. API Manufacturing
6.5.2.1. API Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Finished drug products Manufacturing
6.5.3.1. Finished drug products Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. Medical Devices & Combination Products
6.5.4.1. Medical Devices & Combination Products Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Packaging and Labelling
6.6.1. Packaging and Labelling Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Regulatory Affairs
6.7.1. Regulatory Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Others
6.8.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. U.S. Healthcare Contract Development and Manufacturing Organization Market: Workflow Estimates & Trend Analysis
7.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Workflow: Segment Dashboard
7.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Workflow: Movement Analysis
7.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Workflow, 2021-2033 (USD Million)
7.4. Clinical
7.4.1. Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Commercial
7.5.1. Commercial Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. U.S. Healthcare Contract Development and Manufacturing Organization Market: Therapeutic Area Estimates & Trend Analysis
8.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Therapeutic Area: Segment Dashboard
8.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by Therapeutic Area: Movement Analysis
8.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Infectious Diseases
8.5.1. Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Neurological Disorders
8.6.1. Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7. Cardiovascular Disease
8.7.1. Cardiovascular Disease Market Estimates and Forecasts, 2021-2033 (USD Million)
8.8. Metabolic Disorders
8.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.9. Autoimmune Diseases
8.9.1. Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.10. Respiratory Diseases
8.10.1. Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.11. Ophthalmology
8.11.1. Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
8.12. Gastrointestinal Disorders
8.12.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
8.13. Orthopedic Diseases
8.13.1. Orthopedic Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.14. Dental Diseases
8.14.1. Dental Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
8.15. Others
8.15.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. U.S. Healthcare Contract Development and Manufacturing Organization Market: End Use Estimates & Trend Analysis
9.1. U.S. Healthcare Contract Development and Manufacturing Organization Market, by End Use: Segment Dashboard
9.2. U.S. Healthcare Contract Development and Manufacturing Organization Market, by End Use: Movement Analysis
9.3. U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates & Forecasts, by End Use, 2021-2033 (USD Million)
9.4. Pharmaceutical & Biotechnology Companies
9.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5. Medical Device Companies
9.5.1. Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6. Others
9.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Key Participant Categorization
10.1.1. Market Leaders
10.1.2. Emerging Players
10.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
10.3. Company Profiles
10.3.1. Catalent Inc.
10.3.1.1. Company Overview
10.3.1.2. Financial Performance
10.3.1.3. Service Benchmarking
10.3.1.4. Strategic Initiatives
10.3.2. Lonza
10.3.2.1. Company Overview
10.3.2.2. Financial Performance
10.3.2.3. Service Benchmarking
10.3.2.4. Strategic Initiatives
10.3.3. Recipharm AB
10.3.3.1. Company Overview
10.3.3.2. Financial Performance
10.3.3.3. Service Benchmarking
10.3.3.4. Strategic Initiatives
10.3.4. Siegfried Holding AG
10.3.4.1. Company Overview
10.3.4.2. Financial Performance
10.3.4.3. Service Benchmarking
10.3.4.4. Strategic Initiatives
10.3.5. Thermo Fisher Scientific, Inc.
10.3.5.1. Company Overview
10.3.5.2. Financial Performance
10.3.5.3. Service Benchmarking
10.3.5.4. Strategic Initiatives
10.3.6. Labcorp Drug Development
10.3.6.1. Company Overview
10.3.6.2. Financial Performance
10.3.6.3. Service Benchmarking
10.3.6.4. Strategic Initiatives
10.3.7. Jabil Inc
10.3.7.1. Company Overview
10.3.7.2. Financial Performance
10.3.7.3. Service Benchmarking
10.3.7.4. Strategic Initiatives
10.3.8. Syngene International Limited
10.3.8.1. Company Overview
10.3.8.2. Financial Performance
10.3.8.3. Service Benchmarking
10.3.8.4. Strategic Initiatives
10.3.9. IQVIA Inc.
10.3.9.1. Company Overview
10.3.9.2. Financial Performance
10.3.9.3. Service Benchmarking
10.3.9.4. Strategic Initiatives
10.3.10. Almac Group
10.3.10.1. Company Overview
10.3.10.2. Financial Performance
10.3.10.3. Service Benchmarking
10.3.10.4. Strategic Initiatives
10.3.11. Ajinomoto Bio-Pharma
10.3.11.1. Company Overview
10.3.11.2. Financial Performance
10.3.11.3. Service Benchmarking
10.3.11.4. Strategic Initiatives
10.3.12. Adare Pharma Solutions
10.3.12.1. Company Overview
10.3.12.2. Financial Performance
10.3.12.3. Service Benchmarking
10.3.12.4. Strategic Initiatives
10.3.13. Alcami Corporation
10.3.13.1. Company Overview
10.3.13.2. Financial Performance
10.3.13.3. Service Benchmarking
10.3.13.4. Strategic Initiatives
10.3.14. Vetter Pharma International
10.3.14.1. Company Overview
10.3.14.2. Financial Performance
10.3.14.3. Service Benchmarking
10.3.14.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 4 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 5 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 6 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by Workflow, 2021-2033 (USD Million)
Table 7 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by Therapeutic Area, 2021-2033 (USD Million)
Table 8 U.S. Healthcare Contract Development and Manufacturing Organization Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 U.S. Healthcare Contract Development and Manufacturing Organization Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 U.S. Healthcare Contract Development and Manufacturing Organization Market: Type outlook and key takeaways
Figure 20 U.S. Healthcare Contract Development and Manufacturing Organization Market: Type movement analysis
Figure 21 Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Branded Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Generic Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Biosimilar Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Medical Device Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 U.S. Healthcare Contract Development and Manufacturing Organization Market: Product outlook and key takeaways
Figure 31 U.S. Healthcare Contract Development and Manufacturing Organization Market: Product movement analysis
Figure 32 Pharmaceutical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 Traditional API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 HP-API Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Biologics Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Oral Topical Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Semi-Solid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 Liquid Dose Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Medical Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Class I Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Class II Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Class III Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 U.S. Healthcare Contract Development and Manufacturing Organization Market: Service outlook and key takeaways
Figure 48 U.S. Healthcare Contract Development and Manufacturing Organization Market: Service movement analysis
Figure 49 Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Preformulation & Formulation Development Service Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Process Development & Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Analytical Testing & Method Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Scale-up & Tech Transfer Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 API Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 Finished drug products Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Medical Devices & Combination Products Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 Packaging and Labelling Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Regulatory Affairs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 U.S. Healthcare Contract Development and Manufacturing Organization Market: Workflow outlook and key takeaways
Figure 62 U.S. Healthcare Contract Development and Manufacturing Organization Market: Workflow movement analysis
Figure 63 Clinical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Commercial Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 U.S. Healthcare Contract Development and Manufacturing Organization Market: Therapeutic Area outlook and key takeaways
Figure 66 U.S. Healthcare Contract Development and Manufacturing Organization Market: Therapeutic Area movement analysis
Figure 67 Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 73 Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Orthopedic Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Dental Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 78 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 U.S. Healthcare Contract Development and Manufacturing Organization Market: End Use outlook and key takeaways
Figure 80 U.S. Healthcare Contract Development and Manufacturing Organization Market: End Use movement analysis
Figure 81 Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 82 Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 83 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 84 Key company categorization
Figure 85 Service heat map analysis
Figure 86 Strategic framework

Companies Mentioned

The leading players profiled in this U.S. Healthcare Contract Development and Manufacturing Organization market report include:
  • atalent Inc.
  • onza
  • ecipharm AB
  • iegfried Holding AG
  • hermo Fisher Scientific, Inc.
  • abcorp Drug Development
  • abil Inc
  • yngene International Limited
  • QVIA Inc.
  • lmac Group
  • jinomoto Bio-Pharma
  • dare Pharma Solutions
  • lcami Corporation
  • etter Pharma International

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 70.2 Billion
Forecasted Market Value ( USD ) by 2033 $ 144.2 Billion
Compound Annual Growth Rate9.4%
Regions CoveredUnited States
No. of Companies Mentioned14

Related Topics

Related Reports

Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
U.S. Pharmaceutical Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Services, Workflow, Therapeutic Area, End Use, and Growth Forecasts, 2025-2033 - Product Image

U.S. Pharmaceutical Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Services, Workflow, Therapeutic Area, End Use, and Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From
U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Indication (Infectious Diseases, Metabolic & Genetic Diseases), by Application, by End Use, and Segment Forecasts, 2025-2033 - Product Image

U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Indication (Infectious Diseases, Metabolic & Genetic Diseases), by Application, by End Use, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From
Middle East Pharmaceutical Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Middle East Pharmaceutical Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Middle East
From
Middle East Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Healthcare Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type, Product, Service, Workflow, Therapeutic Area, End-use, and Country with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Middle East
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.